Publication | Closed Access
Phase I Clinical Trial with the AMC-Bioartificial Liver
167
Citations
40
References
2002
Year
Treatment of ALF patients with the AMC-BAL is a safe and feasible technique to bridge the waiting time for an adequate liver-graft.
| Year | Citations | |
|---|---|---|
Page 1
Page 1